NSE: TATACHEM | BSE: 500770

Strong Performer, Under Radar

Download real time

757.65 -7.90 (-1.03%)

New 52W Low in past week

136.2K NSE+BSE Volume

NSE 01 Jan, 2026 11:24 AM (IST)

19,301.6

Market Cap

High in industry

Beta 1Year

High Volatility

Tata Chemicals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for TATACHEM, BSE:500770 Tata Chemicals Ltd.

Search Inside the pdf :

Tata Chemicals Ltd.

24 Dec 2025

757.65

-1.03%

TATA CHEMICALS

Accumulate: Tata Chemicals Ltd.

Target

Geojit BNP Paribas

The company's performance during the quarter was disappointing, due to unfavorable market conditions. Its key segments underperformed, impacted by weak demand for its products across regions, except for India. However, the European business has shown encouraging margin improvement, driven by a favorable product mix. The company expects this momentum to continue, with the business poised to achieve profitability in the near future. Furthermore, the company's prudent capital expenditure investments in expanding its Indian capacity...

Number of FII/FPI investors increased from 270 to 285 in Sep 2025 qtr.

Tata Chemicals Ltd.

03 Nov 2025

757.65

-1.03%

Unfavorable demand-supply dynamics hurt margins

Neutral: Tata Chemicals Ltd.

Target

Motilal Oswal

Tata Chemicals (TTCH)’s 2QFY26 consolidated EBITDA declined 13% YoY, led by subdued performance in America (TCNA)/Africa (TCAHL)/Rallis, with EBITDA down 65%/58%/5% YoY due to a weak demand-supply scenario.

Geojit BNP Paribas decreased Accumulate price target of Tata Chemicals Ltd. to 876.0 on 24 Dec, 2025.

Tata Chemicals Ltd.

29 May 2025

757.65

-1.03%

TATA CHEMICALS

Hold: Tata Chemicals Ltd.

Recommendation Target

Geojit BNP Paribas

TCL faces short-term challenges, including sluggish demand in the US and Europe and decreasing export prices in the US market, as well as downward pressure on *over or under performance to benchmark index margins due to declining soda ash prices. However, the company is well-positioned for growth, driven by its strategic emphasis on speciality products and capacity expansion plans. A recovery in volumes and margins is anticipated in the next fiscal year, led by the Indian and Kenyan markets. The UK business is expected to show signs of improvement from the second quarter, driven by its new pharmaceutical...

Number of FII/FPI investors increased from 270 to 285 in Sep 2025 qtr.

Tata Chemicals Ltd.

17 Oct 2024

757.65

-1.03%

Sequential recovery improves 2H prospects

Neutral: Tata Chemicals Ltd.

Target

Motilal Oswal

TTCH’s 2QFY25 consolidated EBITDA declined 25% YoY, due to lower realizations YoY, higher freight costs and unfavorable operating leverage across geographies.

Tata Chemicals has lost -27.99% in the last 1 Year

Tata Chemicals Ltd.

05 Aug 2024

757.65

-1.03%

Pricing pressure continues to hurt performance

Neutral: Tata Chemicals Ltd.

Motilal Oswal

TTCH’s 1QFY25 consolidated EBITDA declined 45% YoY, due to subdued operating performance across geographies, with India/US/UK/Kenya reporting EBITDA decline of 19%/58%/84%/61% YoY.

Number of FII/FPI investors increased from 270 to 285 in Sep 2025 qtr.

Tata Chemicals Ltd.

07 May 2024

757.65

-1.03%

TATA CHEMICALS

Sell: Tata Chemicals Ltd.

Target

Geojit BNP Paribas

Tata Chemicals has lost -27.99% in the last 1 Year

Tata Chemicals Ltd.

29 Apr 2024

757.65

-1.03%

Operating performance hit by subdued soda ash prices

Neutral: Tata Chemicals Ltd.

Target

Motilal Oswal

Tata Chemicals (TTCH)’s 4QFY24 consolidated EBITDA declined 54% YoY,
primarily due to a subdued operating performance across geographies with
India/US/UK/Kenya reporting 26%/68%/72%/57% decline YoY.